Stocks to watch today

has received letter of acceptance (LoA) worth around Rs 143.37 crore from Southern Railway for upgradation work of electric traction system from 1x25 kv to 2x25 kv traction system from Salem Jn. (SA)-Podanur Jn. (PTJ) & Irugur (IGU)-Coimbatore Jn. (CBE)-Podanur Jn. (PTJ) section of salem division of Southern Railway to meet 3000 MT loading target. The order is to be executed within 24 months. n’s subsidiary -- Biocon Biologics has received marketing authorisations in the United Kingdom (UK) for Vevzuo and Evfraxy, biosimilars of Denosumab, from Medicines and Healthcare products Regulatory Agency (MHRA). Vevzuo is authorized for the prevention of skeletal related events (pathological fracture, radiation to bone, spinal cord compression or surgery to bone) in adults with advanced malignancies involving bone. Evfraxy is authorized for the treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures. In postmenopausal women this significantly reduces the risk of vertebral, non-vertebral, and hip fractures. (CSL) has signed a comprehensive Memorandum of Understanding (MoU) with HD Korea Shipbuilding & Offshore Engineering Co (KSOE), South Korea, on July 04, 2025. The MoU sets the stage for long term cooperation between the two companies in various domains of shipbuilding and maritime development. The MoU covers the joint exploration of new building opportunities in India and abroad; sharing of technical expertise to scale up to the global standards in shipbuilding; identification of initiatives to enhance productivity and capacity utilization; joint efforts to upskill and strengthen workforce; and exploration of potential collaboration in other shipbuilding-related projects.